A PDCA cycle-based early intensive lipid-lowering strategy improves LDL-C goal achievement and clinical outcomes after PCI in acute coronary syndrome patients
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
AIMS: To evaluate whether a PDCA cycle-based early intensive lipid-lowering strategy could improve LDL-C goal attainment in patients with acute coronary syndrome undergoing PCI. METHODS: This retrospective, single-center cohort study enrolled 203 consecutive ACS patients undergoing PCI between January 2022 and January 2025. Patients were assigned to a control group receiving standard lipid-lowering therapy (n=101) or a PDCA intervention group (n=102) managed through a Plan-Do-Check-Act cycle-based early intensive lipid-lowering protocol. The primary endpoint was LDL-C goal attainment at 12 weeks (
Fields of Study & Subjects
Lipoproteins and Cardiovascular Health
Coronary Interventions and Diagnostics
Acute Myocardial Infarction Research
Publication details
- Journal / source
- American Journal of Translational Research
- Volume
- 18
- Issue
- 3
- Pages
- 2072–2085
- Publication date
- 1 January 2026
- Language
- EN